AP - Biotechnology company MedImmune Inc., which recently agreed to be taken over by drug manufacturer AstraZeneca, said Monday that first quarter earnings more than tripled on stronger sales of its childhood respiratory ailment drug Synagis.
AP - Biotechnology company MedImmune Inc., which recently agreed to be taken over by drug manufacturer AstraZeneca, said Monday that first quarter earnings more than tripled on stronger sales of its childhood respiratory ailment drug Synagis.
No comments:
Post a Comment